147 related articles for article (PubMed ID: 35156283)
1. Systematic review and meta-analysis: Associations between metabolic syndrome and colorectal neoplasia outcomes.
Lu L; Koo S; McPherson S; Hull MA; Rees CJ; Sharp L
Colorectal Dis; 2022 Jun; 24(6):681-694. PubMed ID: 35156283
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis.
Wu H; Zhang J; Zhou B
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101749. PubMed ID: 34214702
[TBL] [Abstract][Full Text] [Related]
3. The association of Metabolic Syndrome and its Components with the Incidence and Survival of Colorectal Cancer: A Systematic Review and Meta-analysis.
Han F; Wu G; Zhang S; Zhang J; Zhao Y; Xu J
Int J Biol Sci; 2021; 17(2):487-497. PubMed ID: 33613107
[No Abstract] [Full Text] [Related]
4. Components of metabolic syndrome and metachronous colorectal neoplasia.
Ashbeck EL; Jacobs ET; Martínez ME; Gerner EW; Lance P; Thompson PA
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1134-43. PubMed ID: 19318435
[TBL] [Abstract][Full Text] [Related]
5. Association between metabolic syndrome and early-stage colorectal cancer.
Zhang C; Zhang L; Tian Y; Guan B; Li S
BMC Cancer; 2023 Oct; 23(1):1020. PubMed ID: 37872512
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for metachronous colorectal cancer and advanced neoplasia following primary colorectal cancer: a systematic review and meta-analysis.
Zhang Y; Karahalios A; Aung YK; Win AK; Boussioutas A; Jenkins MA
BMC Gastroenterol; 2023 Nov; 23(1):421. PubMed ID: 38036994
[TBL] [Abstract][Full Text] [Related]
7. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia?
Suchanek S; Grega T; Ngo O; Vojtechova G; Majek O; Minarikova P; Brogyuk N; Bunganic B; Seifert B; Dusek L; Zavoral M
World J Gastroenterol; 2016 Sep; 22(36):8103-11. PubMed ID: 27688652
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract][Full Text] [Related]
9. Risk of Metachronous Colorectal Advanced Neoplasia and Cancer in Patients With 3-4 Nonadvanced Adenomas at Index Colonoscopy: A Systematic Review and Meta-Analysis.
Park S; Jeon SR; Kim HG; Jung Y; Kwak MS; Kim SY; Kim JW; Nam SJ; Oh EH; Park SY; Park SK; Byeon JS; Boo SJ; Baek DH; Yoon SM; Chun J; Lee J; Choi M
Am J Gastroenterol; 2022 Apr; 117(4):588-602. PubMed ID: 35169108
[TBL] [Abstract][Full Text] [Related]
10. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
Choi YJ; Lee DH; Han KD; Shin CM; Kim N
Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
[TBL] [Abstract][Full Text] [Related]
11. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.
Shen X; Wang Y; Zhao R; Wan Q; Wu Y; Zhao L; Wu X
Int J Colorectal Dis; 2021 Oct; 36(10):2215-2225. PubMed ID: 34331119
[TBL] [Abstract][Full Text] [Related]
13. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.
Jinjuvadia R; Lohia P; Jinjuvadia C; Montoya S; Liangpunsakul S
J Clin Gastroenterol; 2013 Jan; 47(1):33-44. PubMed ID: 23090040
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
15. [Natural history of colorectal cancer: a Meta-analysis on global prospective cohort studies].
Huang HY; Zhu SL; Zhou TH; Li ZF; Liu CC; Wang H; Yan SP; Song SM; Zou SM; Zhang YM; Li N; Zhu L; Liao XZ; Shi JF; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jul; 40(7):821-831. PubMed ID: 31357806
[No Abstract] [Full Text] [Related]
16. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
17. Association between Helicobacter pylori infection and the risk of colorectal neoplasia: a systematic review and meta-analysis.
Wu Q; Yang ZP; Xu P; Gao LC; Fan DM
Colorectal Dis; 2013 Jul; 15(7):e352-64. PubMed ID: 23672575
[TBL] [Abstract][Full Text] [Related]
18. Serrated Polyps and the Risk of Metachronous Colorectal Advanced Neoplasia: A Systematic Review and Meta-Analysis.
Jung YS; Park JH; Park CH
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):31-43.e1. PubMed ID: 33007512
[TBL] [Abstract][Full Text] [Related]
19. Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomas.
Hassan C; Gimeno-García A; Kalager M; Spada C; Zullo A; Costamagna G; Senore C; Rex DK; Quintero E
Aliment Pharmacol Ther; 2014 May; 39(9):905-12. PubMed ID: 24593121
[TBL] [Abstract][Full Text] [Related]
20. Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials.
Bonovas S; Fiorino G; Lytras T; Malesci A; Danese S
World J Gastroenterol; 2016 May; 22(18):4594-603. PubMed ID: 27182169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
